Log Out

State of Alaska Department of Revenue Raises Position in Cutera, Inc. (NASDAQ:CUTR)

Defense World · Oct 3, 2022 05:02

State of Alaska Department of Revenue raised its holdings in Cutera, Inc. (NASDAQ:CUTR – Get Rating) by 10.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,499 shares of the medical device company's stock after buying an additional 1,135 shares during the period. State of Alaska Department of Revenue owned approximately 0.07% of Cutera worth $468,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CUTR. Captrust Financial Advisors raised its holdings in shares of Cutera by 592.2% in the 1st quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after purchasing an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Cutera in the 1st quarter valued at $95,000. Everence Capital Management Inc. acquired a new stake in shares of Cutera in the 1st quarter valued at $218,000. Teacher Retirement System of Texas acquired a new stake in shares of Cutera in the 1st quarter valued at $220,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Cutera in the 1st quarter valued at $233,000.

Get Cutera alerts:

Cutera Price Performance

Shares of NASDAQ:CUTR opened at $45.60 on Monday. The company's fifty day moving average price is $47.60 and its 200 day moving average price is $49.42. Cutera, Inc. has a 12 month low of $31.62 and a 12 month high of $74.38. The company has a debt-to-equity ratio of 12.56, a current ratio of 4.36 and a quick ratio of 3.83. The firm has a market capitalization of $892.62 million, a P/E ratio of -12.43 and a beta of 1.84.

Cutera (NASDAQ:CUTR – Get Rating) last posted its quarterly earnings data on Thursday, August 4th. The medical device company reported ($2.53) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by ($2.30). The business had revenue of $64.22 million during the quarter, compared to analyst estimates of $63.42 million. Cutera had a negative net margin of 27.62% and a negative return on equity of 151.43%. The company's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 earnings per share. As a group, sell-side analysts predict that Cutera, Inc. will post -1.88 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CUTR. Piper Sandler reduced their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Friday, August 5th. TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research note on Thursday, July 7th. Maxim Group reiterated a "buy" rating and set a $80.00 price target on shares of Cutera in a research note on Friday, August 5th. Finally, StockNews.com upgraded shares of Cutera to a "sell" rating in a research note on Friday, September 2nd.

Cutera Profile

(Get Rating)

Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.

State of Alaska Department of Revenue Raises Position in Cutera, Inc. (NASDAQ:CUTR)

Cutera Price Performance

Analyst Ratings Changes

Cutera Profile

See Also

Risk Disclaimer